ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,473Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 273

$474K Total Retail Price of All Prescriptions

Rank: 72 out of 273

728 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 728 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 10,855 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
DIGOXIN 781 713 10 1 15
FUROSEMIDE 747 659 2 5
SIMVASTATIN 612 533 3 6
ATENOLOL 586 496 4 17
METOPROLOL TARTRATE 575 529 5 10
CARVEDILOL 548 459 6 3
WARFARIN SODIUM 464 438 7 7
SOTALOL 381 373 8 27
METOPROLOL SUCCINATE 376 339 9 1
HYDROCODONE-ACETAMINOPHEN 301 183 S3 10 48
ATORVASTATIN CALCIUM 284 259 11 8
SPIRONOLACTONE 281 247 12 20
HYDROCHLOROTHIAZIDE 275 267 13 16
AMLODIPINE BESYLATE 269 259 14 2
CLOPIDOGREL 261 241 15 9
ZOLPIDEM TARTRATE 244 219 16 59
AMIODARONE HCL 237 222 17 23
POTASSIUM CHLORIDE 226 181 18 18
BYSTOLIC 209 182 19 26
DILTIAZEM HCL 204 182 20 115
LISINOPRIL 200 148 21 4
PLAVIX 163 145 22 12
NEXIUM 144 134 23 42
LEVOTHYROXINE SODIUM 139 112 24 25
RAMIPRIL 132 132 25 24
OMEPRAZOLE 131 104 26 33
SPIRONOLACTONE-HCTZ 126 109 27 109
DIOVAN 123 111 28 21
PACERONE 93 81 29 85
CRESTOR 91 88 30 14
CLONIDINE HCL 84 62 31 32
NIFEDIPINE ER 83 76 32 43
KLOR-CON M20 82 81 33 39
VYTORIN 81 67 34 68
SERTRALINE HCL 74 58 35 81
ZETIA 72 62 36 30
CAPTOPRIL 71 60 37 136
NIFEDICAL XL 68 64 38 95
ACETAMINOPHEN-CODEINE 66 62 S3 39 164
TORSEMIDE 62 50 40 65
ENALAPRIL MALEATE 62 43 40 31
PRAVASTATIN SODIUM 61 51 42 11
PANTOPRAZOLE SODIUM 58 51 43 41
METOLAZONE 56 48 44 94
PROPAFENONE HCL 55 55 45 57
LIPITOR 54 47 46 29
MELOXICAM 54 51 46 89
PAROXETINE HCL 50 36 48 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.